Passive Heat Therapy for COPD
(COPD Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests whether sitting with legs in hot water can improve blood flow in individuals with Chronic Obstructive Pulmonary Disease (COPD), potentially lowering blood pressure and reducing heart disease risk. Participants will either sit in hot water or a regular warm water footbath to determine if the heat provides benefits similar to exercise. This trial may suit non-smoking individuals over 40 with stable, moderate-to-severe COPD who do not regularly exercise or have certain heart conditions. As an unphased trial, it offers a unique opportunity to explore innovative, non-drug interventions for COPD management.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you cannot participate if you are taking beta blockers.
What prior data suggests that passive heat therapy is safe for people with COPD?
Past studies have shown that passive heat therapy improves heart health and blood flow in older adults, even those with chronic illnesses. Research indicates that this therapy, such as using a hot-water footbath, is generally well-tolerated. No major reports of serious side effects have been linked to this therapy. Evidence from studies on Finnish saunas, another form of passive heat therapy, also suggests they can reduce the risk of certain health issues, supporting the idea that passive heat is safe for most people.12345
Why are researchers excited about this trial?
Most treatments for COPD involve medications like bronchodilators or corticosteroids that help open airways and reduce inflammation. However, passive heat therapy stands out by immersing patients' lower legs in a hot water bath, which is thought to improve circulation and reduce symptoms through heat exposure. This non-invasive approach offers a unique delivery method that might enhance blood flow and oxygenation without the need for pharmaceuticals. Researchers are excited about its potential to offer relief without medication-related side effects, making it a promising alternative or complementary option for managing COPD.
What evidence suggests that passive heat therapy might be an effective treatment for COPD?
Research shows that passive heat therapy, which participants in this trial may receive, can enhance heart and blood vessel health. Studies have found it lowers blood pressure and improves artery health, particularly in older adults, by increasing blood flow. For individuals with chronic health conditions, passive heat therapy has been linked to improved exercise capacity and quality of life. Some research also suggests it can help reduce high blood pressure in the lungs during exercise. These findings indicate that passive heat therapy might offer similar benefits to people with COPD (a lung disease that makes breathing difficult) by improving heart health and blood flow.12345
Who Is on the Research Team?
Neil Eves, PhD
Principal Investigator
Associate Professor
Are You a Good Fit for This Trial?
This trial is for people over 40 with moderate-to-severe COPD who haven't smoked recently and have been stable for at least 6 weeks. It's not for those on Beta Blockers, in exercise programs, with advanced heart or brain vessel disease, uncontrolled high blood pressure, very low blood pressure, or those frequently using hot baths or saunas.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Acute Phase
Participants undergo a single 45-minute session of hot-water footbath to measure acute changes in leg blood flow and exercise tolerance
Treatment
Participants undergo 6 weeks of hot-water footbaths to examine chronic changes in blood flow, blood pressure, and exercise tolerance
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Passive Heat Therapy
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of British Columbia
Lead Sponsor
Canadian Lung Association
Industry Sponsor